James Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. Jim serves as a director at the MIT Jameel Clinic, a member of the Harvard-MIT Health Sciences & Technology Faculty, a core founding faculty member of the Wyss Institute, and a member of the Broad Institute. Jim is also an elected member of all three national academies. As one of the founders of synthetic biology, Jim has pioneered research by using synthetic biology and AI to develop next-generation diagnostics and therapeutics, particularly for infectious diseases such as Ebola, Zika, COVID-19 and antibiotic-resistant bacteria (superbugs). Jim has received numerous awards and honors including recognition as a Clarivate Citation Laureate. The technologies from his lab have been licensed by over 25 biotech, pharmaceutical, and medical device companies, and he has also co-founded a number of biotech startups.
Learn more
Antibiotic resistance is among the biggest global threats to human health. It was directly responsible for an estimated 1.27 million deaths in 2019 and contributed to nearly five million more. The problem only got worse during the COVID pandemic. And no new classes of antibiotics have been developed for decades. Learn more
